RSP:ARCA-Guggenheim S&P 500 Equal Weight

ETF | Others | NYSE Arca

Last Closing

USD 107.84

Change

-0.13 (-0.12)%

Market Cap

USD 10.83B

Volume

0.27M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to replicate as closely as possible, before fees and expenses, the daily performance of the S&P 500? Equal Weight Index Total Return. The fund invests primarily in equity securities to meet its investment objective of replicating the underlying index as closely as possible, before fees and expenses. The underlying index is an unmanaged equal weighted version of the S&P 500? Index, which is an unmanaged capitalization weighted index comprised of 500 common stocks chosen by Standard & Poor's, a Division of The McGraw-Hill Companies, Inc. ("S&P") on a statistical basis. The fund is non-diversified.

Inception Date: 24/04/2003

Primary Benchmark: S&P 500 Equal Weighted TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.4%

Management Expense Ratio: 0.20 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
SCPS Scopus Biopharma Inc 0.23 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-18 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
SOJE SOJE 0.00 %

-0.28 (-1.44%)

USD 65.72B
JEPI JPMorgan Equity Premium Income.. 0.00 %

-0.51 (-0.90%)

USD 32.43B
DTB DTB 0.00 %

-0.39 (-1.96%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2.. 0.00 %

-0.50 (-1.62%)

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC) 0.00 %

-3.55 (-6.33%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET.. 0.00 %

N/A

USD 22.73B
SGOV iShares® 0-3 Month Treasury B.. 0.00 %

+0.01 (+0.01%)

USD 19.79B
CGABL The Carlyle Group Inc. 4.625% .. 0.00 %

-0.61 (-3.26%)

USD 16.14B
AVUV Avantis® U.S. Small Cap Value.. 0.00 %

-2.28 (-2.51%)

USD 10.49B
DFUV Dimensional US Marketwide Valu.. 0.00 %

-0.68 (-1.72%)

USD 10.15B

ETFs Containing RSP

EQL:CA Invesco S&P 500 Equal Wei.. 99.32 % 0.26 %

-0.22 (0%)

CAD 0.87B
EVEN 78.47 % 0.00 %

N/A

N/A
SNAV 28.01 % 0.00 %

N/A

N/A
INAV 23.00 % 0.00 %

N/A

N/A
LEXI Alexis Practical Tactical.. 5.92 % 0.00 %

-0.37 (0%)

USD 0.08B
TBFG The Brinsmere Fund - Grow.. 3.14 % 0.00 %

-0.32 (0%)

USD 0.27B
QUS:AU BetaShares S&P 500 Equal .. 0.89 % 0.00 %

+0.43 (+0%)

USD 0.35B
QEH 0.00 % 1.68 %

N/A

N/A
EQL-F:CA Invesco S&P 500 Equal Wei.. 0.00 % 0.00 %

-0.40 (0%)

N/A
EQL-U:CA Invesco S&P 500 Equal Wei.. 0.00 % 0.00 %

-0.30 (0%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.99% 76% C+ 67% D+
Dividend Return 1.63% 59% D- 38% F
Total Return 19.62% 77% C+ 65% D
Trailing 12 Months  
Capital Gain 6.67% 65% D 61% D-
Dividend Return 1.47% 38% F 27% F
Total Return 8.14% 62% D 57% F
Trailing 5 Years  
Capital Gain 48.09% 82% B 76% C+
Dividend Return 9.64% 44% F 32% F
Total Return 57.73% 81% B- 74% C
Average Annual (5 Year Horizon)  
Capital Gain 7.08% 82% B 73% C
Dividend Return 8.62% 81% B- 69% C-
Total Return 1.54% 48% F 35% F
Risk Return Profile  
Volatility (Standard Deviation) 8.87% 59% D- 76% C+
Risk Adjusted Return 97.14% 88% B+ 88% B+
Market Capitalization 10.83B 97% N/A 89% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.